Loading...

 

What is it about?

Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by progressive motor and non-motor symptoms. Current treatments primarily focus on symptomatic relief, highlighting the need for disease-modifying therapies. Main Focus: This review article explores the potential of sphingosine-1-phosphate (S1P) signalling as a novel therapeutic target for PD management. S1P signalling plays a crucial role in cellular processes, including cell survival, differentiation, and migration. Key Findings: 1. S1P signalling regulates neuroprotection and neuroregeneration in PD. 2. S1P receptors modulate neuroinflammation, oxidative stress, and mitochondrial dysfunction. 3. Preclinical studies demonstrate the efficacy of S1P-targeting compounds in PD models. 4. S1P signalling interacts with other PD-related pathways, offering opportunities for combination therapies.

Featured Image

Why is it important?

This review article holds significant importance in neuroscience and neurology, particularly in seeking effective treatments against Parkinson's disease (PD). Here's why: 1. Bridging basic and clinical research: The review connects fundamental research on S1P signalling to potential clinical applications. 2. Interdisciplinary collaborations: The article encourages collaboration among neuroscientists, pharmacologists, and clinicians. Importance for Researchers and Clinicians 1. Updates on cutting-edge research 2. Identification of potential therapeutic targets 3. Insights into S1P signalling's mechanisms and interactions Societal Impact 1. Improved healthcare outcomes for PD patients 2. Enhanced quality of life for patients and caregivers 3. Economic benefits through reduced healthcare costs and improved productivity

Perspectives

Sorry, your browser does not support inline SVG.

I aim to make the seemingly dry topic of health economics and health measurement engaging and captivating. The reality is, how we allocate resources for health and social care affects every individual worldwide, making it a universal concern that transcends policy and academia. My hope is that this article sparks reflection and inspires new perspectives, demonstrating the profound impact of health economics on our collective well-being.

Dr Jai Parkash Kadian
Shobhit University

Read the Original

This page is a summary of: Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease, Drug Research, October 2024, Thieme Publishing Group,
DOI: 10.1055/a-2401-4578.
You can read the full text:

Read

Contributors

The following have contributed to this page